期刊文献+

支气管肺癌黏膜Cath D、SP-A和GLUT-1的表达及临床意义 被引量:2

The Expression of Cath D,SP-A,GLUT-1 of Bronchiogenic Carcinoma
下载PDF
导出
摘要 目的了解支气管肺癌活组织黏膜组织蛋白酶D(Cath D)、肺表面活性物质相关蛋白A(SP-A)和组织葡萄糖转运蛋白1(GLUT-1)的表达。方法支气管镜下钳取异常组织黏膜41例,经光镜病理确诊为支气管肺癌38例(其中小细胞肺癌10例,鳞状细胞癌28例),炎症3例。用SP免疫组织化学方法检测Cath D、SP-A和GLUT-1的表达。结果①Cath D:小细胞癌-6例(60%),++4例(40%);鳞状细胞癌-4例(14%),+2例(7%),++8例(28%),+++14例(50%)。小细胞癌与鳞状细胞癌对Cath D的表达有明显差异(P<0.01),后者明显高于前者。鳞状细胞癌分化程度不同,Cath D的表达有明显差异(P<0.05),分化程度越低,表达越高;②SP-A:+++3例(炎症),++20例(高分化鳞癌15例,中分化鳞癌5例),+6例(中分化鳞癌),-12例(小细胞癌10例,低分化鳞癌2例);③GLUT-1:小细胞癌-6例,+2例,+++2例;鳞状细胞癌-5例,+7例,++11例,+++5例;炎症+++3例。小细胞癌与鳞状细胞癌对GLUT-1的表达有明显差异(P<0.05),后者明显高于前者;不同分化程度的鳞状细胞癌,GLUT-1的表达无差异(P(0.05);炎症与鳞癌GLUT-1表达有明显差异(P<0.05)与小细胞癌则无差异(P(0.05)。结论 Cath D有助于鳞状细胞癌的诊断和分化程度的评估,SP-A可能有助支气管黏膜炎症与高恶度肿瘤组织的鉴别,GLUT-1在鳞状细胞癌有高表达,有助于鳞状细胞癌的诊断和鉴别诊断。 Objective To examine the expression of Cath D, SP - A and GLUT - 1 in patients with bronchiogenic carcinoma. Methods A total of 41 patients were included in the study, 10 of whom received the histological diagnosis of small cell lung cancer (SCLC) . The other 28 were squamous cell carcinoma (SC) and 3 were inflammation. And all the samples were taken from the patients' tunica mucosa bronchiorum through bronchofibroscope, then we detected the cathepsin D, SP - A and GLUT - following SP immunohis- tochemistry. Results ①Cath D: 6 samples (60%) in group SCLC were negtive expression (-6) , 4 (40%)were moderately positive (++4), 4 (14%) were negative (-4), 2 (7%) were positive (+2), 8 (28%) were moderately positive (++8) and 14 (50%) were intensive positive ( +++ 14) in the other group. SCLC was significant different from SC in expressing cathepsin D (P 〈0.01 ) , and the latter group was obviously exceeded with the former one. At the same time, the level of expression depended on the degree of the squamous cell differentiation ( P 〈 0.05 ) ; ②SP - A : + + + for 3 (inflammatory) , + + for 20 ( 15 were high differentiation squamous cell carcinoma; others were middle differentiation squamous cell carcinoma) , + for 6 (middle differentiation squamous cell carcinoma) and - for 12( 10 were small cell carcinoma and 2 were poorly differentiated squamous cell carcinoma) were found;③GLUT - 1 :strong positive was 10 including 3 inflammatory and 7 well differentiated squamous cell carcinoma; positive was 11 (squamous cell carcinoma) ; weakly posi- tive was 9 (2 of them were small cell carcinoma, others were quamous cell carcinoma) ; negative was 6 (small cell carcinoma). Conclu- sion The detection of cathepsin D is of great clinical significance in diagnosing and evaluating differentiation - degree in squamous cell carcinoma. The SP - A may contribute to identification of the tissue belong to bronchial mucosa. The high expression of GLUT - 1 in SC is of great clinical significance in tumor diagnosis.
出处 《医学研究杂志》 2010年第3期70-73,共4页 Journal of Medical Research
基金 吉林省教育厅"十一五"科学技术研究项目(吉教科字2007第244号)
关键词 支气管异常黏膜 组织蛋白酶D 肺表面活性物质相关蛋白A 组织葡萄糖转运蛋白1 Bronehiogenie carcinoma Cathepsin D Pulmonary suffactant - associated protein - A ( SP - A) Glucose transporter - 1 ( GLUT - 1 )
  • 相关文献

参考文献10

二级参考文献51

  • 1[1]Mendez LE,Manci N,Cantuaria G,et al.Expression of glucose transporter-1 in cervical cancer and its precursors.Gynecol Oncol,2002,86(2):138-143.
  • 2[2]Haber RS,Rathan A,Weiser KR,et al.GLUT1 glucose transporter expression in colorectal carcinoma:a marker for poor prognosis.Cancer,1998,83(1):34-40.
  • 3[4]Chung JK.Lee YJ,Kim SK,et al.Comparison of[18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer.Nucl Med Commun,2004,25(1):11-17.
  • 4[5]Kawamura T,Kusakabe T,Sugino T,et al.Expression of glucose transporter-1 in human gastric carcinoma:association with tumor aggressiveness,metastasis,and patient survival.Cancer,2001,92(3):634-641.
  • 5[6]Alo PL,Visca P,Botti C,et al.Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue.Am J Clin Pathol,2001,116(1):129-134.
  • 6[7]Bos R,van Der Hoeven JJ,van Der Wall E,et al.Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.J Clin Oncol,2002,20(2):379-387.
  • 7[8]Haber RS,Rathan A,Weiser KR,et al.GLUT1 glucose transporter expression in colorectal carcinoma:a marker for poor prognosis.Cancer,1998,83(1):34-40.
  • 8[9]Brown RS,Leung JY,Fisher SJ,et al.Intratumoral distribution of tritiated-FDG in breast carcinoma:correlation between Glut-1 expression and FDG uptake.J Nucl Med,1996,37 (6):1042-1047.
  • 9[10]Shikhman AR,Brinson DC,Valbracht J,et al.Cytokine regulation of facilitated glucose transport in human articular chondrecytes.J Immunol,2001,167(12):7001-7008.
  • 10[11]Ogawa J,Inoue H,Koide S.Glucose-transporter-type-Ⅰ-gene amplification correlates with sialyl-Lewis-Ⅹ synthesis and proliferation in lung cancer.Int J Cancer,1997,74(2):189-192.

共引文献14

同被引文献11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部